Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB2275

Introduced
7/15/25  

Caption

Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025

Impact

The impact of SB2275 on state laws and healthcare policy could be significant. It encourages the dissemination of information regarding uterine fibroids, including their prevalence among different demographics and the range of available treatment options. The bill also instructs the Secretary of Health and Human Services to enhance research efforts, potentially increasing the understanding of fibroid-related issues, especially in underrepresented populations. By authorizing necessary appropriations for these initiatives, it aims to mitigate the long-standing underfunding of uterine fibroid research at the federal level, thus aligning future healthcare practices more closely with the needs of affected individuals.

Summary

SB2275, known as the Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025, is a legislative proposal aimed at addressing the significant health issues caused by uterine fibroids among women, particularly focusing on minority populations. The bill seeks to allocate substantial funding for research and develop public education initiatives regarding the awareness, incidence, and treatment options available for uterine fibroids. Given that a noticeable percentage of women experience symptoms associated with fibroids that can severely affect their quality of life, such as pelvic pain and heavy menstrual bleeding, this bill intends to provide both medical and educational resources to better manage these health concerns.

Contention

Notable points of contention surrounding SB2275 may arise from discussions about the allocation of federal research funds, especially given the historical context where uterine fibroid research has received significantly less attention compared to other health issues. Critics may highlight the challenges in ensuring that the research translates effectively into practice for minority populations, who often experience disparities in healthcare access, diagnosis, and treatment. The effectiveness of proposed public education campaigns could also be scrutinized to ensure that they reach the intended audiences and lead to real improvements in healthcare outcomes.

Companion Bills

US HB4395

Related Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025

Previously Filed As

US SB2303

Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023

US HB4572

Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023

US HR1580

Supporting the designation of July as Uterine Fibroids Awareness Month.

US HB8247

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024

US HB9782

Uterine Cancer Study Act of 2024

US HB8601

Liver Illness Visibility, Education, and Research Act of 2024

US HB10297

Thyroid Disease CARE Act of 2024 Thyroid Disease Coverage, Awareness, Research, and Education Act of 2024

US HB4135

AG RESEARCH Act Augmenting Research and Educational Sites to Ensure Agriculture Remains Cutting-edge and Helpful Act

US HB10439

To amend the Public Health Service Act to expand research and education with respect to endometrial cancer, and for other purposes.

US HB7213

Autism Collaboration, Accountability, Research, Education, and Support Act of 2024 Autism CARES Act of 2024

Similar Bills

CA SB536

Firearm Violence Research Center: gun violence restraining orders.

CA AB922

Reproductive health and research: oocyte procurement.

CA AB818

Protective orders.

CA SB442

State parks: resource exploitation exceptions: commercialization of investigation results.

CA SB706

Public health: pulmonary hypertension task force.

CA AB829

Richard Paul Hemann Parkinson’s Disease Program: Parkinson’s Disease Research Voluntary Tax Contribution Fund.

CA SB391

Community colleges: Chancellor of the California Community Colleges: data request fee policy.

CA SB440

Personal income taxes: voluntary contributions: California Breast Cancer Research Voluntary Tax Contribution Fund and California Cancer Research Voluntary Tax Contribution Fund.